Espansione Group

Casa
Italia
Argelato
Espansione Group

We Science Onward. Redefining Paradigms in Ophthalmology and Beyond.

Since 1981, Espansione Group has delivered the highest standard in the Ophthalmology and Dermatology industries—pushed on by expert craftsmanship and family-owned values coupled with a global mindset and aspiration. Every day, we invest heavily in researching and developing the Espansione Ecosystem of technologies and solutions to achieve our ambition. Our ambition isn’t limited to that of becomin

g the undisputed thought leader in diagnosing and treating ocular surface conditions. Beyond that, we aim at leveraging our know-how and applying it synergically in other fields beyond ophthalmology. We have already delivered great degrees of innovation to the fields of ophthalmology and dermatology through our patented technology Light Modulation® Low-Level Light Therapy and its seamless integration in the Espansione Ecosystem of solutions. LM® LLLT has set a new medical standard in painlessly and effectively treating the majority of ocular surface conditions, on top of being extremely effective in its dermatology applications.

03/09/2026

One ecosystem. Multiple technologies. A shared vision for the future of eye care.

At ESCRS 2026 in London, Espansione Group, Essilor Instruments and Heidelberg Engineering come together under the EssilorLuxottica MedTech ecosystem.

A place where diagnostic insights, clinical expertise and therapeutic innovation connect to shape new possibilities in ophthalmology.

📍 Visit us at Booth B.300 at ExCeL London.

Explore our scientific programme at the Leonardo in Conversation theatre, featuring:

🔬 15+ Espansione scientific sessions
🗣️ International KOLs discussing the latest advances in ophthalmic care
👁️ The evolving role of Light Modulation™ Low-Level Light Therapy (LM™ LLLT) in anterior segment applications, including refractive and cataract surgery pathways

Want the complete line-up?
👉 Download the full schedule here: https://espansionegroup.it/surgical-enhancement-pathways/

Science advances when knowledge is shared.
See you at ESCRS 2026.

31/08/2026

Great vision starts with a healthy ocular surface.

In our interviews with leading ophthalmic experts across different congresses, we explored the clinical challenges that can make the difference between an expected outcome and a truly successful one.

For Dr. Sheraz Daya, ocular surface management is a key part of the vision correction journey. A stable tear film, a healthy cornea and controlled inflammation are not just about patient comfort — they can also influence measurements, surgical outcomes and the need for further interventions.

As he puts it: identifying and addressing ocular surface issues before surgery can make all the difference.

🎥 Watch the interview with Dr. Sheraz Daya to hear his perspective on why ocular surface management should be part of every vision correction strategy.

11/08/2026

Light Modulation™ LLLT is changing the conversation around ocular surface management.

At ESCRS 2026, Espansione Group will join Heidelberg Engineering under the EssilorLuxottica MedTech ecosystem at Booth B.300.

From expert-led scientific sessions to abstracts and posters presented throughout the congress, discover how Light Modulation™ Low-Level Light Therapy (LM™ LLLT) is contributing to the evolving approach to ocular surface optimisation before and after cataract and refractive surgery.

📍 Visit us at Booth B.300, ExCeL London.

Stay tuned—we'll be sharing more over the coming weeks.

06/08/2026

Every clinical experience contributes to a better understanding of how light-based therapies can support the management of ocular surface disease.

In this clinical case shared by Dr. Sarah Farrant, OD (UK), an 80-year-old patient with Dry Eye Disease associated with meibomian gland dysfunction (MGD), blepharitis and excess microbial load, clinically observed as saponification along the eyelid margin, underwent four treatment sessions combining Red and Blue LM™ LLLT (PBM) with OPE™ IPL.

Following treatment, a substantial improvement in the quality and viscosity of meibomian gland secretions was observed, together with the complete resolution of saponification.

While every patient presents unique clinical characteristics, this case illustrates the potential of combining photobiomodulation and intense pulsed light to address multiple underlying mechanisms of evaporative Dry Eye Disease, supporting meibomian gland function, eyelid margin health and microbial balance.

We thank Dr. Sarah Farrant for sharing her clinical experience and contributing to the growing body of real-world evidence supporting light-based approaches in the management of Dry Eye Disease and blepharitis.

27/07/2026

Knowledge only makes a difference when it's put into practice.
The future of Dry Eye care is built on the patient journey.

Over the past weeks, we've explored the growing burden of Dry Eye Disease, the importance of early recognition and the value of evidence-based diagnosis.
Now it's time for the final step: translating knowledge into everyday clinical practice.

Promoted by Espansione Group (part of EssilorLuxottica) as part of the global educational initiative developed in collaboration with the Tear Film & Ocular Surface Society (TFOS) and hosted on the Leonardo EssilorLuxottica platform, this concluding webinar brings together the key themes explored throughout the series and focuses on how to successfully integrate Dry Eye management into daily practice.

Join Dr. Paul Karpecki as he shares practical strategies for building efficient clinical workflows, improving patient communication, setting realistic treatment expectations and integrating innovative technologies—including Light Modulation™ Low-level Light Therapy (LM™ LLLT)—into a comprehensive, patient-centred model of care.

Because better Dry Eye outcomes are achieved through more than a single treatment—they are the result of a structured patient journey, delivered consistently from diagnosis through long-term management.

Webinar details
📅 July 29
🕔 5:00 PM (CEST)
🎙 Dr. Paul Karpecki – Kentucky Eye Institute, USA

👉 Secure your spot. Let's advance Dry Eye care, together. https://leonardo.essilorluxottica.com/?courseDetail=lp14036

23/07/2026

's is often missed for years, and the eye is frequently where it shows up first.

On World Sjögren's Day, we want to acknowledge the role eye care practitioners play in recognising it early. Ocular dryness is among the earliest and most burdensome manifestations, and it is rarely purely aqueous-deficient.
TFOS DEWS III Report reinforces that most dryeye is mixed in nature, which means the evaporative component warrants attention even when the underlying pathology is autoimmune and lacrimal in origin.

That premise underpins the work of Dr. Di Marino and colleagues (2021, Journal of Ophthalmology), a prospective series in which 20 patients with 's received LM™ LLLT combined with OPE™ IPL.
Tear film break-up time improved progressively over three months and symptom scores fell at both one and three months, most markedly at one month, with no ocular or facial adverse events reported. While more work is needed, this is a testament to the potential of our tech, and a foundation on which we plan on building a better future for patients.

We believe advancing ocular surface care starts with science. That is why we continue to develop evidence-based light technologies designed to support a deeper understanding and more effective management of dry eye disease.

16/07/2026

Diagnosis is only the beginning.
The next step is choosing the right management pathway.

Once Dry Eye Disease has been identified, patients need a treatment approach that is evidence-based, personalized and tailored to their specific needs.

As part of Dry Eye Awareness Month, Espansione Group (part of EssilorLuxottica), in collaboration with Tear Film & Ocular Surface Society (TFOS), continues its educational initiative with a third webinar exploring how innovative technologies are helping reshape the way we manage Dry Eye Disease.

Join Prof. Dr. James Wolffsohn as he discusses evidence-based management strategies, with a special focus on the role of Light Modulation™ Low-level Light Therapy (LM™ LLLT) and Optimal Power Energy™ IPL delivered through the eye-light® platform.

Discover how light-based technologies can complement conventional therapies, support a personalized treatment approach and help clinicians meet the evolving needs of Dry Eye patients.

Webinar details:
📅 July 21
🕓 4:00 PM (CEST)
🎙 Prof. James Wolffsohn – Aston University, United Kingdom

👉 Secure your spot. Let's advance Dry Eye care, together.
https://leonardo.essilorluxottica.com/?courseDetail=lp14036

15/07/2026

Dry Eye Awareness Month is an opportunity to highlight the importance of accurate diagnosis and effective treatment approaches for patients affected by Dry Eye Disease.

This clinical case reports the outcomes achieved with LM™ LLLT (PBM) delivered using eye-light® in a 73-year-old woman diagnosed with Dry Eye Disease due to meibomian gland dysfunction (MGD), blepharitis and superficial punctate keratitis.

At baseline, the patient reported severe symptoms, with an Ocular Surface Disease Index (OSDI) score of 77. Tear-film stability was also reduced, with tear break-up times of 4 seconds in the right eye and 2 seconds in the left eye.

After four treatment sessions, the OSDI score decreased to 29, showing a clinically meaningful improvement in symptoms.
Tear-film stability improved as well, with break-up times increasing to 8 seconds in the right eye and 6 seconds in the left eye.

Additional improvements were observed in ocular-surface staining and eyelid-margin inflammation.

These results are consistent with the recommendations of the TFOS DEWS III report, which supports the use of LM™ LLLT in patients with eyelid anomalies, including MGD, and ocular surface abnormalities, including cellular damage.

Thank you to Dr. Carmela Sannace, MD, for sharing this clinical case and contributing to the growing body of evidence supporting new approaches in Dry Eye Disease management.

10/07/2026

Awareness alone isn't enough.
Early recognition is what changes patient outcomes.

Although Dry Eye Disease affects millions of people worldwide, its signs and symptoms don't always align—making early recognition one of the biggest challenges in everyday clinical practice.

Promoted by Espansione Group (part of EssilorLuxottica) as part of the global educational initiative developed in collaboration with Tear Film & Ocular Surface Society (TFOS), and hosted on the Leonardo EssilorLuxottica platform, this second webinar focuses on one of the most critical steps in the patient journey: screening for and diagnosing Dry Eye Disease earlier and more effectively.

Join Prof. Jennifer Craig as she shares practical, evidence-based approaches to screening, diagnosis and patient communication, helping clinicians recognize DED with greater confidence and know when further investigation is needed.

Because earlier diagnosis is the foundation for better management—and for unlocking innovative treatment pathways, including Light Modulation™ Low-level Light Therapy (LM™ LLLT).

Webinar details:
📅 July 15
🕕 8:00 AM (CEST)
🎙 Prof. Jennifer Craig - University of Auckland, New Zealand

👉 Secure your spot. Let's advance Dry Eye care, together. https://leonardo.essilorluxottica.com/?courseDetail=lp14036

07/07/2026

Dry Eye Disease isn't just more common.
It's becoming impossible to ignore.

This Dry Eye Awareness Month, join us for the first session of Advancing Care in Dry Eye Disease—the global educational webinar series promoted by Espansione Group (part of EssilorLuxottica) as part of the broader awareness initiative developed in collaboration with Tear Film & Ocular Surface Society (TFOS).

Our opening webinar welcomes Prof. José Alvaro Pereira Gomes, who will examine the growing burden of Dry Eye Disease and explain why earlier recognition is critical to improving patient care.

From increasing screen time and ageing populations to environmental and lifestyle changes, discover the factors reshaping Dry Eye Disease—and why awareness is the foundation for better diagnosis, better management and better outcomes.

📅 July 9
🕛 5 PM (CEST)
🎙 Prof. José A. P. Gomes - Federal University of São Paulo, Brazil

👉 Secure your spot. Let's advance Dry Eye care, together. https://leonardo.essilorluxottica.com/?courseDetail=lp14036

Indirizzo

Blocco 27 – Via Degli Orefici 152
Argelato
40050

Sito Web

http://espansionegroup.it/

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando Espansione Group pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.